Ashland/$ASH
1D1W1M3M6MYTD1Y5YMAX
Capital at risk
About Ashland
Ashland Inc. is a specialty materials company serving markets including pharmaceuticals, personal care, food and beverages, coatings, construction, energy, and electronics. It operates through four segments: Life Sciences, Personal Care, Specialty Additives, and Intermediates. Life Sciences contributes the highest revenue, offering functional additives for pharmaceutical and nutrition applications. Personal Care provides ingredients for skin, hair, oral care, and household products, while Specialty Additives supplies performance-enhancing additives for coatings and. Intermediates produce BDO and related derivatives used in polymers, electronics, agriculture, and pharmaceutical applications. The company generates sales across North America, Europe, Asia Pacific, Latin America, and regions.
- Ticker
- $ASH
- Sector
- Materials
- Primary listing
- NYSE
- Employees
- 2,900
- Headquarters
- Wilmington, United States
- Website
- www.ashland.com
Ashland Metrics
BasicAdvanced
$3.3B
62.93
$1.15
0.41
$1.67
2.32%
Price and volume
Market cap
$3.3B
Beta
0.41
52-week high
$78.25
52-week low
$47.12
Average daily volume
580K
Dividend rate
$1.67
Financial strength
Current ratio
3.047
Quick ratio
1.642
Long term debt to equity
0.78
Total debt to equity
0.789
Dividend payout ratio (TTM)
146.15%
Interest coverage (TTM)
4.61%
Profitability
EBITDA (TTM)
364
Gross margin (TTM)
34.96%
Net profit margin (TTM)
2.82%
Operating margin (TTM)
11.51%
Effective tax rate (TTM)
40.00%
Revenue per employee (TTM)
$640,000
Management effectiveness
Return on assets (TTM)
2.88%
Return on equity (TTM)
3.99%
Valuation
Price to earnings (TTM)
62.932
Price to revenue (TTM)
1.777
Price to book
1.78
Price to tangible book (TTM)
5.04
Price to free cash flow (TTM)
15.886
Free cash flow yield (TTM)
6.29%
Free cash flow per share (TTM)
4.552
Dividend yield (TTM)
2.31%
Forward dividend yield
2.32%
Growth
Revenue change (TTM)
-1.44%
Earnings per share change (TTM)
-106.16%
3-year revenue growth (CAGR)
-7.22%
10-year revenue growth (CAGR)
-6.34%
3-year earnings per share growth (CAGR)
-36.06%
10-year earnings per share growth (CAGR)
-9.16%
3-year dividend per share growth (CAGR)
6.20%
10-year dividend per share growth (CAGR)
0.65%
What the Analysts think about Ashland
Analyst ratings (Buy, Hold, Sell) for Ashland stock.
Analyst projections of the future price of Ashland stock.
Bulls say / Bears say
Ashland’s higher-value Life Sciences and Personal Care franchises are showing solid demand: third-quarter sales rose 11% and 5%, respectively, with pharma recording its fifth straight quarter of volume growth. This gives the company a stronger growth base than its weaker industrial markets. (Ashland)
Cash generation and balance-sheet metrics provide resilience: Ashland generated $103 million of ongoing free cash flow in the third quarter and ended it with 2.4x net leverage, back within its long-term target range. That gives it more flexibility to invest and manage weaker markets. (Ashland)
A sale process is a possible source of extra value: Bloomberg reported that an activist investor was pressing Ashland to sell, after another investor had also called for a sale. This is a potential catalyst, not a confirmed transaction. (Bloomberg)
Earnings are not yet converting the sales growth into stronger profit: third-quarter sales rose 7%, but adjusted EBITDA fell 4% and its margin narrowed to 21.9% from 24.4%. Higher production costs and inflationary pressure were among the factors weighing on results. (Ashland)
Some end markets remain weak: Ashland reported continuing softness in construction and energy-related demand, while Intermediates earnings also fell year on year. A prolonged industrial or EV-related slowdown could limit improvement outside its stronger consumer and pharma businesses. (Ashland, Ashland)
Data summarised monthly by Lightyear AI. Last updated on 18 Oct 2026.
Ashland Financial Performance
Revenues and expenses
Ashland Earnings Performance
Company profitability
Upcoming events
No upcoming events
Ashland News
AllArticlesVideos
Funds containing Ashland
AllUSDEURGBP
Fund name | Fund size | $ASH weighting |
|---|---|---|
SPDR Russell 2000 US Small Cap€R2US | $5.3B | 0.12% |
SPDR Russell 2000 US Small Cap£R2SC | $5.3B | 0.12% |
SPDR S&P 400 US Mid Cap£SPX4 | $6.4B | 0.10% |
SPDR S&P 400 US Mid Cap$SPY4 | $6.4B | 0.10% |
SPDR MSCI USA Small Cap Value Weighted$USSC | $1.1B | 0.09% |
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.